In vivo evidence for cerebral depletion in high-energy phosphates in progressive supranuclear palsy (Q46134947)

19 December 2017

title

In vivo evidence for cerebral depletion in high-energy phosphates in progressive supranuclear palsy (English)

1 reference

19 December 2017

author

Carmen Schade-Brittinger

8

object named as

Carmen Schade-Brittinger

1 reference

19 December 2017

9

Wolfgang H Oertel

1 reference

19 December 2017

1

Maria Stamelou

1 reference

19 December 2017

6

Susanne Knake

1 reference

19 December 2017

Karla M. Eggert

5

object named as

Karla M Eggert

1 reference

19 December 2017

author name string

Ulrich Pilatus

2

1 reference

19 December 2017

Alexander Reuss

3

1 reference

19 December 2017

Jörg Magerkurth

4

1 reference

19 December 2017

Merle Ruberg

7

1 reference

19 December 2017

Günter U Höglinger

10

1 reference

19 December 2017

publication date

4 February 2009

1 reference

19 December 2017

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

19 December 2017

volume

29

1 reference

19 December 2017

issue

4

1 reference

19 December 2017

page(s)

861-870

1 reference

19 December 2017

Further evidence for mitochondrial dysfunction in progressive supranuclear palsy

cites work

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Regulation of oxidative phosphorylation in the mammalian cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Control of respiration and ATP synthesis in mammalian mitochondria and cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Stress-induced mitochondrial depolarization and oxidative damage in PSP cybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

The FAB: a Frontal Assessment Battery at bedside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

A clinical rating scale for progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Evaluation of optimal echo time for 1H-spectroscopic imaging of brain tumors at 3 Tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Effects of ischaemia on content of metabolites in rat liver and kidney in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Quantitative (31)P spectroscopic imaging of human brain at 4 Tesla: assessment of gray and white matter differences of phosphocreatine and ATP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Phosphorylation status of liver by 31P-n.m.r. spectroscopy, and its implications for metabolic control. A comparison of 31P-n.m.r. spectroscopy (in vivo and in vitro) with chemical and enzymic determinations of ATP, ADP and Pi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Inorganic Phosphate Is Transported into Mitochondria in the Absence of ATP Biosynthesis: Anin Vivo31P NMR Study in the Human Skeletal Muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Lactate quantification by proton magnetic resonance spectroscopy using a clinical MRI machine: a basic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Cerebral intracellular pH by 31P nuclear magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Cerebral energy metabolism in phenylketonuria: findings by quantitative In vivo 31P MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

21 January 2018

Mitochondrial disease

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Current and future treatments in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Improved Method for Accurate and Efficient Quantification of MRS Data with Use of Prior Knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

Proton magnetic resonance spectroscopy of patients with parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

7 January 2021

Assessment of absolute metabolite concentrations in human tissue by 31P MRS in vivo. Part I: Cerebrum, cerebellum, cerebral gray and white matter

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

7 January 2021

Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

7 January 2021

Threshold Effects in Synaptosomal and Nonsynaptic Mitochondria from Hippocampal CA1 and Paramedian Neocortex Brain Regions

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

7 January 2021

Muscle mitochondrial ATP production in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

7 January 2021

Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

7 January 2021

'Secondary' 4216/ND1 and 13708/ND5 Leber's hereditary optic neuropathy mitochondrial DNA mutations do not further impair in vivo mitochondrial oxidative metabolism when associated with the 11778/ND4 mitochondrial DNA mutation

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

7 January 2021

Deficit of brain and skeletal muscle bioenergetics in progressive supranuclear palsy shown in vivo by phosphorus magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

7 January 2021

Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

7 January 2021

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

7 January 2021

Parkinson's disease and brain mitochondrial dysfunction: a functional phosphorus magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1038/JCBFM.2009.2

7 January 2021

Identifiers

DOI

10.1038/JCBFM.2009.2

1 reference

19 December 2017

release_hhjhwzj67nga3cwrmwmoqjzcmq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hhjhwzj67nga3cwrmwmoqjzcmq

24 November 2022

mapped directly with Wikidata item

1 reference

19 December 2017